Ab Dynamics PLC Q&A with CEO Tim Rogers (LON:ABDP)
14 August 2017
For investors with a keen eye on the healthcare sector, Personalis, Inc. (NASDAQ: PSNL) presents an intriguing opportunity. Specializing in advanced cancer genomic tests and services, the company is at..
REGENXBIO Inc. (NASDAQ: RGNX) is a prominent player in the biotechnology sector, with a focus on developing innovative gene therapy solutions through its proprietary NAV Technology Platform. With a market..
In the dynamic world of biotechnology, Septerna, Inc. (NASDAQ: SEPN) emerges as a compelling player with a focus on developing innovative treatments for a spectrum of diseases. Based in South..
Pharvaris N.V. (NASDAQ: PHVS), a Switzerland-based biotechnology firm, is making waves in the healthcare sector with its innovative approach to treating rare diseases, particularly angioedema. With a market capitalization of..
Investors with an eye on the biotechnology sector might find EyePoint, Inc. (NASDAQ: EYPT) a compelling opportunity, especially given its potential upside of 183.45%. EyePoint is carving a niche in..
Cross Country Healthcare, Inc. (NASDAQ: CCRN), a significant player in the healthcare sector specializing in medical care facilities, is currently trading at $8.74, which reflects a slight decline of 0.02%...
Investors looking to explore opportunities within the biotechnology sector may find Fortrea Holdings Inc. (FTRE) intriguing, especially given its potential for a 19.10% upside based on current analyst ratings. As..
Investors with an interest in the biotechnology sector might find Valneva SE (NASDAQ: VALN) an intriguing opportunity. This French-based specialty vaccine company, with a market cap of $808.98 million, is..
MeiraGTx Holdings plc (NASDAQ: MGTX), a prominent player in the biotechnology sector, is catching the attention of investors with its remarkable potential for substantial returns. The company, specializing in genetic..
InnovAge Holding Corp. (NASDAQ: INNV) is at the forefront of providing comprehensive medical and ancillary services tailored for seniors who wish to live independently. Operating through the Program of All-Inclusive..
Cronos Group Inc. (NASDAQ: CRON), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, continues to capture investor attention with its strategic operations..
AbCellera Biologics Inc. (NASDAQ: ABCL), a pioneering player in the biotechnology sector, has become a focal point for investors looking to capitalize on its significant growth potential. Headquartered in Vancouver,..
uniQure N.V. (QURE), a prominent player in the biotechnology sector, stands out as a fascinating investment opportunity with a staggering potential upside of 117.08%. Operating out of Amsterdam, Netherlands, the..
Treace Medical Concepts, Inc. (NASDAQ: TMCI) is an intriguing name in the healthcare sector, specifically within the medical devices industry. The company, headquartered in Ponte Vedra, Florida, specializes in innovative..
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) stands out in the biotechnology sector with its ambitious focus on developing gene therapies for monogenic diseases of the central nervous system. With a..
Investors looking for promising opportunities in the healthcare sector may find Akso Health Group (AHG) an intriguing candidate. Based in Qingdao, China, this company has carved a niche within the..
For investors seeking opportunities in the healthcare sector, RxSight, Inc. (NASDAQ: RXST) offers a compelling narrative, especially with a potential upside of 32.85% based on analyst price targets. Specializing in..
Investors seeking exposure in the burgeoning field of virtual healthcare might find Talkspace, Inc. (NASDAQ: TALK) to be a compelling opportunity. With a market capitalization of $634.7 million, Talkspace is..
Zenas BioPharma, Inc. (NASDAQ: ZBIO) is emerging as a noteworthy player in the biotechnology sector, capturing investor interest with its promising pipeline and substantial potential upside of 93.96%. Headquartered in..
Sionna Therapeutics, Inc. (NASDAQ: SION), a notable player in the biotechnology sector, is making waves with its ambitious approach to treating cystic fibrosis (CF). With a market capitalization of $1.57..
